The 2019 Drug Pricing and Reimbursement Stakeholder Summit is dedicated to the current and future changes to the pricing landscape as it shifts in response to administrative changes.
Topics
- Methods for approaching the changes of the pricing landscape
- Drug pricing transparency on a federal and state level along with its current and anticipated impact on all sectors
- Value-based pricing from multiple perspectives in order to gain a full understanding of the key players involved
- Definitive practices within drug pricing in order to minimize uncertainties brought about by administrative decisions
- Multi-stakeholder perspectives on the future of drug pricing and the implications it has on organizational functions
Who should Attend
Senior attendees from pharmaceutical, biotechnology, and medical device companies with responsibilities in:
- Reimbursement
- Pricing
- Legal/Counsel/Regulatory
- Market Access
- Government Pricing/Programs
- Government Affairs
- Commercial Operations
- Compliance
- Corporate Communications
- Account Management
- Insurance Provider Relationships
- Contract Negotiations
- Quality Management
- Commercial Development
